Medicare

Annual Medicare Expense for Anti-VEGF Injections Tops $4 Billion, Study Finds

A significant rise ($1.5 billion more per year) can be attributed to greater uptake of aflibercept by retina specialists. Regional differences reflect local variation in disease burden.
02/21/2024

Age-related Eye Diseases Higher in Prevalence, Incidence Over 15 Years

While the trends reported represent small changes, due to the size of the US Medicare beneficiary population these differences equate to a large number of individuals and considerable economic cost.
07/26/2023

Lack of Eye Care Access in US Reflects Socioeconomic Trends

Patients with Medicare in areas that were rural, had lower household incomes or higher unemployment rates did not make significant use of available services.
05/30/2023

Upcoming Events

May 17-19, 2024

New Technologies & Treatments in Eye Care and Intrepid Eye Society's Spring Conference

Location: Omni La Costa, Carlsbad, California
Co-Chairs: Paul M. Karpecki, OD, and Selina McGee, OD

Register here

November 15-17, 2024

New Technologies & Treatments in Eye Care and Intrepid Eye Society's Fall Conference
Location: Grand Hyatt Nashville
Co-Chairs: Paul Karpecki, OD,  and Selina McGee, OD

Register here